Anika Therapeutics (ANIK) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $997000.0.
- Anika Therapeutics' Interest & Investment Income rose 14556.65% to $997000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 921.66%. This contributed to the annual value of $2.3 million for FY2024, which is 108.13% up from last year.
- According to the latest figures from Q3 2025, Anika Therapeutics' Interest & Investment Income is $997000.0, which was up 14556.65% from $214000.0 recorded in Q2 2025.
- In the past 5 years, Anika Therapeutics' Interest & Investment Income registered a high of $997000.0 during Q3 2025, and its lowest value of -$154000.0 during Q1 2022.
- Moreover, its 5-year median value for Interest & Investment Income was $415000.0 (2025), whereas its average is $354789.5.
- Within the past 5 years, the most significant YoY rise in Anika Therapeutics' Interest & Investment Income was 100833.33% (2022), while the steepest drop was 25813.95% (2022).
- Over the past 5 years, Anika Therapeutics' Interest & Investment Income (Quarter) stood at -$47000.0 in 2021, then soared by 687.23% to $276000.0 in 2022, then skyrocketed by 109.06% to $577000.0 in 2023, then increased by 28.94% to $744000.0 in 2024, then soared by 34.01% to $997000.0 in 2025.
- Its Interest & Investment Income stands at $997000.0 for Q3 2025, versus $214000.0 for Q2 2025 and $415000.0 for Q1 2025.